How Is DuPont Stock Performing in 2017?
DuPont’s stock price
DuPont (DD) stock has had a good performance in 2017 and has outperformed the broad-based SPDR S&P 500 ETF (SPY), which has returned 5.8%. On a year-to-date basis, DuPont has risen 8.4% and outperformed peer Eastman Chemical (EMN), which returned 6.6%. However, DD has underperformed Dow Chemical (DOW) and LyondellBasell (LYB), which have risen 10.8% and 8.6%, respectively.
Interested in DD? Don't miss the next report.
Receive e-mail alerts for new research on DD
DuPont’s stock performance has primarily been driven by its guidance for higher operating earnings by 8% in 1Q17 due to cost savings. Also, DuPont has settled PFOA (perfluorooctanoic acid and its salts) litigation involving approximately 3,500 lawsuits related to claims arising from environment releases of PFOA. Plus, EU regulators are set to approve the DuPont and Dow Chemical merger, which has boosted the company’s stock performance.
Moving average and relative strength index
On February 23, 2017, DuPont stock closed at $79.59 and traded 9.5% above its 100-day moving average price of $72.70, indicating an upward trend in the stock. DD’s 52-week low is $60.69, while its 52-week high is $80.66.
The 14-day relative strength index (or RSI) of 70 indicates that the stock is in the overbought zone. An RSI score of 70 indicates that a stock has moved temporarily into an overbought situation. An RSI score below 30 indicates that a stock has moved temporarily into an oversold position.
Continue to the subsequent parts of this series for a detailed analysis on DD’s latest dividend, analysts’ latest recommendations, and its most recent valuations.